Excel with Evidera

Value and Evidence Planning

“The evidence generation plan was a well-thought-out and concise strategic plan enabling alignment with senior internal stakeholders and setting budgeting priorities for the next two to three years.”
Global Value Strategy Lead, Top 40 Pharmaceutical Company

Services & Products

  • Publications

    Publication

    The Early Engagement Model in Product Development: Linking "Proof of Concept" to "Proof of Medical Value." Ther Innov Regul Sci. 2016 Sep;50(5):592-601. doi: 10.1177/2168479016642816. ABSTRACT
    See More
  • Webinars

    Webinar

    Real-World Data Strategy and Programs of Research: A Roadmap for Late Phase Success

    Presenters: Krista Payne, MEd, Vice President, Late Phase Studies, Real-World Evidence, Evidera; Dimitra Lambrelli, PhD, Research Scientist, Real-World Evidence, Evidera

    Additional Info
    Contact us for slides
    Recording

    Webinar

    Adaptive Pathways and HTAs: Trade-offs in Implementation between Speed and Uncertainty

    Presenters: Susanne Michel, MD, European Practice Leader, Payer Strategy; Yvonne Beatrice Boehler, MD, MBA, Prof. TH Koln University; Agnes Benedict, MA, MSc, Sr. Research Scientist, M&S and Exec. Dir. Center of Excellence - HE; Noemi Muszbek, MA, MSc, Sr. Research Scientist, M&S

    Additional Info
    Contact us for slides

    Webinar

    An Integrated Approach to Value Demonstration: Designing and Implementing a Successful Product Strategy

    Presenters: L. Clark Paramore, MSPH, (formerly with Evidera); Pamela A. Murray, MSc, Director, Business Development, Evidera

    Additional Info
    Contact us for slides
    Recording
  • White Papers

    Whitepaper

    Addressing Unique Challenges Faced by Small to Medium Biopharma in Value Demonstration

    Authors: L. Clark Paramore, MSPH, (formerly with Evidera)

    Year: 2015

    View

    Whitepaper

    Valuing Your Orphan Drug with Appropriate Evidence

    Authors: Jeff Anderson, PhD, Principal Consultant, Strategy Solutions, Evidera

    Year: 2014

    View

    Whitepaper

    Avoid Last Minute Rush- Planning Ahead for Successful Global Market Access

    Authors: Teresa Wilcox, RPh, PhD, Senior Research Leader, Strategy Solutions, Evidera; Rob Thwaites, MA, MCom, Vice President, Health Economics and Epidemiology, Evidera

    Year: 2014

    View
    See More

Evidera’s thought leaders have guided preparation for, and interactions with, the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute for Health and Care Excellence (NICE) and the German Federal Joint Committee (GBA). Our experts have influenced decision making through work with NICE, the Institute for Quality and Efficiency in Healthcare (IQWiG), the FDA, the Centers for Medicare & Medicaid Services (CMS) and France’s Haute Autorité de Santé (HAS).

We draw from the insight and experience of experts across Evidera as well as our network of external collaborators. This breadth of knowledge and depth of experience provides valuable strategic intelligence to help identify a product’s value proposition and determine the best approaches for generating the right evidence to support that value proposition. Our strategic guidance will help you improve the positioning of your product and its market access potential.

Offerings

Value and Evidence Planning (Including Evidence Generation Plan)

Identify the optimal strategy for generating the appropriate evidence to support your product’s value proposition and deliver it to target decision makers at the right time.

Strategic Program Management

Ensure the components of your multifaceted evidence generation plan are strategically integrated and coordinated to deliver the highest quality evidence in a cost-efficient and timely manner.

Value and Evidence Planning Experts

Services & Products

  • Publications

    Publication

    The Early Engagement Model in Product Development: Linking "Proof of Concept" to "Proof of Medical Value." Ther Innov Regul Sci. 2016 Sep;50(5):592-601. doi: 10.1177/2168479016642816. ABSTRACT
    See More
  • Webinars

    Webinar

    Real-World Data Strategy and Programs of Research: A Roadmap for Late Phase Success

    Presenters: Krista Payne, MEd, Vice President, Late Phase Studies, Real-World Evidence, Evidera; Dimitra Lambrelli, PhD, Research Scientist, Real-World Evidence, Evidera

    Additional Info
    Contact us for slides
    Recording

    Webinar

    Adaptive Pathways and HTAs: Trade-offs in Implementation between Speed and Uncertainty

    Presenters: Susanne Michel, MD, European Practice Leader, Payer Strategy; Yvonne Beatrice Boehler, MD, MBA, Prof. TH Koln University; Agnes Benedict, MA, MSc, Sr. Research Scientist, M&S and Exec. Dir. Center of Excellence - HE; Noemi Muszbek, MA, MSc, Sr. Research Scientist, M&S

    Additional Info
    Contact us for slides

    Webinar

    An Integrated Approach to Value Demonstration: Designing and Implementing a Successful Product Strategy

    Presenters: L. Clark Paramore, MSPH, (formerly with Evidera); Pamela A. Murray, MSc, Director, Business Development, Evidera

    Additional Info
    Contact us for slides
    Recording
  • White Papers

    Whitepaper

    Addressing Unique Challenges Faced by Small to Medium Biopharma in Value Demonstration

    Authors: L. Clark Paramore, MSPH, (formerly with Evidera)

    Year: 2015

    View

    Whitepaper

    Valuing Your Orphan Drug with Appropriate Evidence

    Authors: Jeff Anderson, PhD, Principal Consultant, Strategy Solutions, Evidera

    Year: 2014

    View

    Whitepaper

    Avoid Last Minute Rush- Planning Ahead for Successful Global Market Access

    Authors: Teresa Wilcox, RPh, PhD, Senior Research Leader, Strategy Solutions, Evidera; Rob Thwaites, MA, MCom, Vice President, Health Economics and Epidemiology, Evidera

    Year: 2014

    View
    See More
Back to Top